# Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots PROOF OF CONCEPT

> **NCT05014321** · NA · COMPLETED · sponsor: **Cryonove Pharma** · enrollment: 12 (actual)

## Conditions studied

- Lentigo Solar

## Interventions

- **DEVICE:** EC16 medical device (CE marked)
- **DEVICE:** device prototype (810A-v1)
- **DEVICE:** device prototype (810B-v1)
- **DEVICE:** device prototype (810C-v1)

## Key facts

- **NCT ID:** NCT05014321
- **Lead sponsor:** Cryonove Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-14
- **Primary completion:** 2021-05-20
- **Final completion:** 2021-07-16
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-06-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05014321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05014321, "Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots PROOF OF CONCEPT". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05014321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*